Shopping Cart
Remove All
Your shopping cart is currently empty
MIL62 is a glycoengineered type II anti-CD20 monoclonal antibody with an Fc region N-glycan that is almost entirely afucosylated. It exhibits increased affinity for the FcγRⅢa receptor and possesses direct B-cell killing effects. MIL62 displays antibody-dependent cell-mediated cytotoxicity (ADCC) and is applicable for research in non-Hodgkin's lymphoma (NHL).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | MIL62 is a glycoengineered type II anti-CD20 monoclonal antibody with an Fc region N-glycan that is almost entirely afucosylated. It exhibits increased affinity for the FcγRⅢa receptor and possesses direct B-cell killing effects. MIL62 displays antibody-dependent cell-mediated cytotoxicity (ADCC) and is applicable for research in non-Hodgkin's lymphoma (NHL). |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.